<DOC>
	<DOCNO>NCT01522898</DOCNO>
	<brief_summary>Cardiac resynchronization therapy ( CRT ) treatment heart failure patient also suffer ventricular dyssynchrony , form uncoordinated contraction ventricle ( low pump chamber heart ) . In past decade , CRT become establish treatment heart failure patient normal rhythm , call sinus rhythm . An important subset heart failure patient atrial fibrillation ( AF ) , make around 1 4 HF patient , over-represented amongst HF patient advance symptom . In heart failure patient AF , CRT proven effective sinus rhythm , due competition beat generate CRT device beat conduct heart 's electrical conduction system . In current study , aim test hypothesis ablate AV node , control electrical conduction heart 's atrium ( top chamber ) ventricle ( low chamber ) , improve survival heart failure symptom CRT patient co-existent AF . The result important , provide way pass benefit CRT , improve survival , less heart failure symptom , good quality life , heart failure patient also suffer AF .</brief_summary>
	<brief_title>Cardiac Resynchronisation Therapy AV Nodal Ablation Trial Atrial Fibrillation Patients ( CAAN-AF )</brief_title>
	<detailed_description>Background : Cardiac Resynchronization Therapy ( CRT ) establish treatment heart failure ( HF ) patient ventricular dyssynchrony remain sinus rhythm . Available clinical data show inferior outcome CRT HF patient co-existent atrial fibrillation ( AF ) , comprise 27 % HF patient , over-represented advance HF class . We hypothesize , base result systematic review recently publish Journal American College Cardiology , AV nodal ablation may improve survival , heart failure functional outcome CRT recipients co-existent AF . Design : This study multicentre , prospective , randomize control trial . Patients ischemic nonischemic cardiomyopathy heart failure ( NYHA II , III ambulatory class IV ) , leave ventricular dysfunction ( EF ≤ 35 % ) , prolong intraventricular conduction ( QRS duration ≥ 120ms ) , persistent permanent AF consider study . Persistent AF define patient obtain maintain sinus rhythm deem either worthwhile , ineffective long term , patient physician accept presence AF , rhythm control intervention , definition , long pursue . Permanent AF define AF sinus rhythm restore . Eligible subject randomize one two arm : ( 1 ) CRT-D plus AV nodal ablation ( `` AV nodal ablation arm [ AVNA ] '' ) ( 2 ) CRT-D alone ( `` rate control arm '' ) . Enrollment : 590 subject , 295 subject AV node ablation arm 295 subject control arm , enrol . Study patient undergo stratified randomization ≥ 30 day CRT implant . Participants sign inform consent screen prior randomisation . After CRT implant , patient least 30 day optimisation heart failure therapy , prior randomisation . Randomisation : A computer-generated web-based randomisation schedule use . Randomisation stratify trial centre . Randomisation consider trial entry point . Outcomes : The primary endpoint composite cause mortality non-fatal heart failure event . Secondary endpoint include all-cause mortality , cardiovascular mortality ( include classification term suddenness arrhythmic mechanism prespecified Hinkle-Thaler criterion ) , non-fatal heart failure event , 6-minute walk test distance , quality life , unplanned hospitalization , ventricular arrhythmia require device therapy , inappropriate shock , cardiovascular MRI prediction response , percentage pace prediction response therapy , ventricular reverse remodel . Statistical Plan : The study power find 25 % relative reduction event rate , sample size calculate assume two-tailed α=0.05,1-β=0.80 , 10 % sample size increment allow drop event rate ( AV nodal ablation arm ) , drop cross-over ( feasibly , control AVNA arm ) . It plan perform three interim ( 0.25 , 0.5 0.75 information fraction ) final analysis require 295 patient per arm final P-value ≤ 0.045 ; stopping rule accord method O'Brien Fleming . The boundary ( z score : ±4.332 , ±2.963 , ±2.359 , ±2.014 ; nominal P-values : 0.000015 , 0.0031 , 0.014 , 0.044 ) ) derive use statistical package PASS ( V12 ) . Outside defined analysis , Data Safety Monitoring Board ( DSMB ) access data report able stop trial time . All analysis base intention-to-treat principle . The primary ( binary ) mortality-outcome analyse use Cochran-Mantel-Haenszel statistic logistic regression pre-specified ( baseline ) covariates . Time-to-event analysis initially undertaken Kaplan-Meier survival analysis approach . Key secondary outcome all-cause mortality , cardiovascular mortality , unplanned hospitalisation , rate ventricular arrhythmia episode analyse use either Cox proportional hazard model Fine Gray compete risk regression appropriate . Continuous secondary outcome 6-minute walk distance , Short Form 36 ( SF36 ) score , Minnesota Living Heart Failure ( MLWHF ) score compare randomise group time use linear mixed effect model . Significance Impact : The study answer central clinical question directly impact care HF patient AF , expect change current HF management guideline .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Age ≥ 18 year old Persistent ( ≥ 1 month ) permanent atrial fibrillation . Persistent AF obtain maintain sinus rhythm deem either worthwhile , ineffective long term , patient physician accept presence AF , rhythm control intervention , definition longer pursue . Permanent AF define atrial fibrillation sinus rhythm restore . NYHA class II , III ambulatory class IV heart failure Left Ventricular Ejection Fraction ( LVEF ) ≤ 35 % objective criterion echocardiography , cardiac MRI QRS duration 12lead ECG ≥ 120ms Able willing comply pre , post followup testing requirement . age &lt; 18 year pregnancy previous AV nodal ablation Second third degree AV block Inability provide inform consent life expectancy le 24 month due comorbid illness heart failure erg cancer , endstage renal disease , liver failure Paroxysmal Atrial Fibrillation self terminate within 7 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Atrial Fibrillation</keyword>
</DOC>